Literature DB >> 16115979

Cumulative and bolus in vitro contracture testing with 4-chloro-3-ethylphenol in malignant hyperthermia positive and negative human skeletal muscles.

Mark Ulrich Gerbershagen1, Marko Fiege, Ralf Weisshorn, Kerstin Kolodzie, Jochen Schulte am Esch, Frank Wappler.   

Abstract

In this study we evaluated the in vitro effects of 4-chloro-3-ethylphenol (CEP) using cumulative (12.5-200 micromol/L) or bolus (75 and 100 micromol/L) administrations, on muscle specimens from malignant hyperthermia (MH) susceptible and MH nonsusceptible patients, respectively. In the cumulative CEP in vitro contracture test, contractures were significantly greater in the MH susceptible compared with the MH nonsusceptible muscles in all concentrations between 25 and 100 micromol/L. There was no overlap between the diagnostic groups at 75 micromol/L of CEP, so this test appears to be feasible for diagnosis of MH susceptibility. The two bolus tests are not diagnostically useful, as overlaps between the diagnostic groups were observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115979     DOI: 10.1213/01.ANE.0000160534.23519.1B

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  The ryanodine receptor agonist 4-chloro-3-ethylphenol blocks ORAI store-operated channels.

Authors:  Bo Zeng; Gui-Lan Chen; Nikoleta Daskoulidou; Shang-Zhong Xu
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  4-Chloro-3-ethyl-phenol.

Authors:  Sean H Majer; Joseph M Tanski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.